Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
XKH-001 in Dermatitis, Atopic: NCT07054736 Clinical Landscape Report 2026
15 October 2026
NCT07054736 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
DIT-309 in Osteosarcoma: NCT07052383 Clinical Landscape Report 2026
15 October 2026
NCT07052383 clinical landscape for Osteosarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Mesna in Acute Myeloid Leukemia: NCT07052370 Clinical Landscape Report 2026
15 October 2026
NCT07052370 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Obecabatagene autoleucel in Lupus Nephritis: NCT07053800 Clinical Landscape Report 2026
15 October 2026
NCT07053800 clinical landscape for Lupus Nephritis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tebentafusp in Uveal Melanoma: NCT07057596 Clinical Landscape Report 2026
15 October 2026
NCT07057596 clinical landscape for Uveal Melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Izalontamab Brengitecan in Endometrial Carcinoma: NCT07054567 Clinical Landscape Report 2026
15 October 2026
NCT07054567 clinical landscape for Endometrial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cladribine in Acute Myeloid Leukemia: NCT07053020 Clinical Landscape Report 2026
15 October 2026
NCT07053020 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Nimotuzumab in Non-Muscle Invasive Bladder Neoplasms: NCT07053735 Clinical Landscape Report 2026
15 October 2026
NCT07053735 clinical landscape for Non-Muscle Invasive Bladder Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
JY-231 in Sjogren's Syndrome: NCT07059169 Clinical Landscape Report 2026
15 October 2026
NCT07059169 clinical landscape for Sjogren's Syndrome: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
![[18F]CSB-321 in Uveal Melanoma: NCT07057349 Clinical Landscape Report 2026](https://synapse-static-patsnap-com.libproxy1.nus.edu.sg/strapi-static/Blog_cover_12_7f0c44f64f.jpg)
9 min read
[18F]CSB-321 in Uveal Melanoma: NCT07057349 Clinical Landscape Report 2026
15 October 2026
NCT07057349 clinical landscape for Uveal Melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Venetoclax in Acute Myeloid Leukemia: NCT07060001 Clinical Landscape Report 2026
15 October 2026
NCT07060001 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Aldesleukin in Uveal Melanoma: NCT07063875 Clinical Landscape Report 2026
15 October 2026
NCT07063875 clinical landscape for Uveal Melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.